-Reuters
Invitae Released A New Study In JAMA Network Open Clinical Practice Guidelines Recommend Genetic Testing Of All Patients With Breast Cancer
Invitae study reports universal genetic testing improves outcomes for patients with breast cancer –
SAN FRANCISCO, Sept. 22, 2022 /PRNewswire/ -- Invitae (NYSE:NVTA), a leading